External quality assessment for the detection of blood-borne viruses in plasma by nucleic acid amplification technology: the first human immunodeficiency virus and hepatitis B virus studies (HIV EQA/1 and HBV EQA/1) and the fifth hepatitis C virus study (HCV EQA/5).

@article{Pisani2004ExternalQA,
  title={External quality assessment for the detection of blood-borne viruses in plasma by nucleic acid amplification technology: the first human immunodeficiency virus and hepatitis B virus studies (HIV EQA/1 and HBV EQA/1) and the fifth hepatitis C virus study (HCV EQA/5).},
  author={Giulio Pisani and K Giesbrecht Cristiano and John Saldanha and Maria Wirz and Guillermo Mario Bisso and Claudio Mele and Giuliano Gentili},
  journal={Vox sanguinis},
  year={2004},
  volume={87 2},
  pages={
          91-5
        }
}
BACKGROUND AND OBJECTIVES This External Quality Assessment (EQA) study was aimed at assessing the proficiency of blood centres and blood product manufacturers in detecting, by nucleic acid amplification technology (NAT), the possible contamination of plasma with hepatitis C virus (HCV), human immunodeficiency virus (HIV) and hepatitis B virus (HBV). MATERIALS AND METHODS Three independent panels, one for each virus, were prepared at the Istituto Superiore di Sanità (ISS) by diluting the… CONTINUE READING
BETA

Similar Papers

Loading similar papers…